TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Results for "feuerstein vyvanse"

Biotech Stock Mailbag: Trump, Aurinia, Immunomedics, Cellceutix

Biotech Stock Mailbag: Why Intrexon CEO R.J. Kirk should not be trusted

  • May 13, 2016 6:00 AM EDT
CTI Biopharma Posts Positive Myelofibrosis Study Results

Why Alcobra Investors Are So Nervous About a Coming Drug Study

  • Sep 24, 2014 9:04 AM EDT
Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest

J.P. Morgan: Biotech Stocks Heading Higher in 2013

  • Jan 2, 2013 7:15 AM EST
Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest

Biotech Stock Mailbag: Catalyst Pharma, Amarin, Star Scientific

  • Oct 26, 2012 8:00 AM EDT
ESMO Preview: Cancer Stocks to Watch

Biotech Stock Mailbag: Clinical Data, Mannkind and Thanks!

  • Dec 17, 2010 7:00 AM EST

What's on Lilly's Prescription Pad?

  • Mar 31, 2009 2:20 PM EDT
Ziopharm Co-Dependency Spirals Down in Amended Intrexon Deal

For AMAG, FDA Delay Only a Flesh Wound

  • Dec 23, 2008 11:42 AM EST

Shire Earnings Impress

  • Apr 25, 2007 12:59 PM EDT

New River's Rough Waters

  • Feb 2, 2007 9:38 AM EST

Biotech Notebook: Hythiam, Shire, Genentech

  • Nov 13, 2007 12:38 PM EST

Shire Shrugged Off

  • Mar 2, 2007 11:20 AM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.